• Profile
Close

Comorbidities in multiple sclerosis—a plea for interdisciplinary collaboration to improve the quality of life of MS patients

Degenerative Neurological and Neuromuscular Disease Jun 18, 2019

Goischke HK - Via a single-blind study, the authors intended to study the therapeutic effectiveness of add-on therapy of vitamin D (VD) and to determine its effective doses for the maintenance of functional and social independence in patients with multiple sclerosis (MS). As there were evidences recorded that VD deficiency has a correlation with brain atrophy, recognition of VD as a “multipurpose steroid hormone” could also be used to maintain cognitive function and prevent premature possible dementia. Hence, it was concluded that vitamin D add-on therapy would be an almost unproblematic and most likely to be accepted by patients with MS.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay